user

CHOOSING AND DEVELOPING CORE OUTCOME MEASUREMENT SETS FOR CLINICAL TRIALS: OUTCOME MEASURES IN RHEUMATOID ARTHRITIS CLINICAL TRIALS FILTER 2.0

被引：0
|
作者：
Boers, Maarten [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I116
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [31] Trials in rheumatoid arthritis:: choosing the right outcome measures -: comment on the article by Felson et al
    Porter, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (09) : 1356 - 1356
  • [32] A roadmap to help with the adoption of core outcome sets in eczema clinical trials
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (06) : E109 - E109
  • [33] Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
    Dworkin, RH
    Turk, DC
    Farrar, JT
    Haythornthwaite, JA
    Jensen, MP
    Katz, NP
    Kerns, RD
    Stucki, G
    Allen, RR
    Bellamy, N
    Carr, DB
    Chandler, J
    Cowan, P
    Dionne, R
    Galer, BS
    Hertz, S
    Jadad, AR
    Kramer, LD
    Manning, DC
    Martin, S
    McCormick, CG
    McDermott, MP
    McGrath, P
    Quessy, S
    Rappaport, BA
    Robbins, W
    Robinson, JP
    Rothman, M
    Royal, MA
    Simon, L
    Stauffer, JW
    Stein, W
    Tollett, J
    Wernicke, J
    Witter, J
    PAIN, 2005, 113 (1-2) : 9 - 19
  • [34] Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia
    Li, Geng
    Han, Ruxue
    Lin, Mingjun
    Wen, Zehuai
    Chen, Xiankun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] Outcome Measures for Clinical Trials in Down Syndrome
    Esbensen, Anna J.
    Hooper, Stephen R.
    Fidler, Deborah
    Hartley, Sigan L.
    Edgin, Jamie
    d'Ardhuy, Xavier Liogier
    Capone, George
    Conners, Frances A.
    Mervis, Carolyn B.
    Abbeduto, Leonard
    Rafii, Michael
    Krinsky-McHale, Sharon J.
    Urv, Tiina
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2017, 122 (03): : 247 - 281
  • [36] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
  • [37] OUTCOME MEASURES FOR CLINICAL-TRIALS IN RHEUMATOLOGY
    TUGWELL, P
    BUCHANAN, W
    BOMBARDIER, C
    EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION, 1983, 6 (02) : 140 - 141
  • [38] Outcome Measures in Clinical Trials for Multiple Sclerosis
    van Munster, Caspar E. P.
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2017, 31 (03) : 217 - 236
  • [39] Outcome measures for clinical drug trials in autism
    Aman, MG
    Novotny, S
    Samango-Sprouse, C
    Lecavalier, L
    Leonard, E
    Gadow, KD
    King, BH
    Pearson, DA
    Gernsbacher, MA
    Chez, M
    CNS SPECTRUMS, 2004, 9 (01) : 36 - 47
  • [40] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    CNS Drugs, 2017, 31 : 217 - 236
12345